biosimilars - the next big thing | kiran mazumdar shaw to et now
Published 4 years ago • 1.8K plays • Length 8:50Download video MP4
Download video MP3
Similar videos
-
14:27
kiran mazumdar-shaw of biocon briefs biosimilar market | et now exclusive
-
4:24
kiran mazumdar shaw on introduction of adalimumab biosimilar
-
1:48
biocon-mylan launch semglee: a biosimilar insulin glargine in the us | kiran majumdar shaw to et now
-
15:10
cracking the biosimilar code with biocon's kiran mazumdar shaw
-
7:26
biocon biologies ipo, debt reduction strategy & more | kiran mazumdar-shaw & peter bains
-
6:50
biocon's kiran mazumdar shaw on strong q4, biosimilar business & fy24 outlook | halftime report
-
11:37
biocon, one of india’s top pharma stocks, won’t focus on india
-
5:04
how biotechnology could change the face of cosmetics
-
9:42
10 reasons why biotech is booming
-
22:15
biocon acquires viatris' biosimilars biz: kiran mazumdar-shaw on deal rationale & growth road map
-
0:43
expect growth to come from biosimilars: biocon
-
12:26
biocon's kiran shaw on biosimilars space
-
5:15
a $6 billion biosimilar opportunity
-
4:52
kiran mazumdar shaw on biosimilars
-
8:31
in insulin bio-similars, our only competitors are original manufacturers: kiran mazumdar shaw,biocon
-
5:58
the availability of multiple biosimilars for 1 biologic
-
7:42
world's first biosimilar drug for breast cancer (wion wallet)
-
4:36
the present and future of biosimilars: opportunity abounds
-
1:39:51
going big with innovative science: from idea to product
-
1:23
indian drug regulator set to launch revised guidelines for biosimilars
-
4:52
kiran mazumdar shaw on biosimilars